Confirmation of BioSyent Inc. 2013 AGM Location

(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 05/17/13 -- BioSyent Inc. ("BioSyent") (TSX VENTURE: RX) today announced that certain documents (the Proxy and the VIF) that have been mailed to shareholders in connection with the 2013 annual general meeting to be held on June 19, 2013 at 9:00 a.m. EST (the "Meeting") contain an incorrect address for the location of the Meeting. The correct location of the Meeting is The Sheraton Toronto Airport Hotel & Conference Centre in the Spartan Room at 801 Dixon Road, Toronto, Ontario M9W 1J5.

The Company will not mail amended materials for the Meeting. Shareholders who prefer not to vote via the internet or by proxy are welcome to attend the Meeting in person.

About BioSyent Inc.

Listed on the Toronto Venture Exchange under the trading symbol "RX", BioSyent is a profitable growth oriented specialty pharmaceutical company which searches the globe to in-license or acquire innovative pharmaceutical products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives of patients and supporting the healthcare professionals that treat them.

Once a product of interest has been found, BioSyent then acquires the exclusive rights to the product and manages it through the Canadian governmental regulatory approval process. Once approved, BioSyent markets the product throughout Canada.

At the date of this press release the Company had 13,571,195 shares issued and outstanding.



Contacts:
BioSyent Inc.
Mr. René C. Goehrum
President and CEO
(905) 206-0013

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: Marketwired
Datum: 17.05.2013 - 20:01 Uhr
Sprache: Deutsch
News-ID 261368
Anzahl Zeichen: 0

contact information:
Town:

TORONTO, ONTARIO

Kategorie:

Alternative

Diese Pressemitteilung wurde bisher 273 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Confirmation of BioSyent Inc. 2013 AGM Location"
steht unter der journalistisch-redaktionellen Verantwortung von

BioSyent Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

BioSyent Releases Q1 2017 Results ...

TORONTO, ONTARIO -- (Marketwired) -- 05/25/17 -- BioSyent Inc. ("BioSyent") (TSX VENTURE: RX) released today a summary of its financial results for the three months ended March 31, 2017. Key highlights include:"Q1 2017 marked BioSyen ...

BioSyent Schedules Q1 2017 Earnings Release for May 25, 2017 ...

TORONTO, ONTARIO -- (Marketwired) -- 05/16/17 -- BioSyent Inc. ("BioSyent") (TSX VENTURE: RX) will be reporting its financial results for the three months ended March 31, 2017 on Thursday, May 25, 2017 at 8:00am (ET). A presentation on th ...

FeraMAX(R) Named #1 by Canadian Physicians and Pharmacists for Second Consecutiv ...

TORONTO, ONTARIO -- (Marketwired) -- 05/01/17 -- Editors note: There is one image accompanying this press release.BioSyent Inc. ("BioSyent") (TSX VENTURE: RX) is pleased to announce that FeraMAX® has been named the #1 recommended iron su ...

Alle Meldungen von BioSyent Inc.